Fiche publication
Date publication
juin 2026
Journal
Journal for immunotherapy of cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BOIDOT Romain
,
Pr GHIRINGHELLI François
,
Pr PAUL Catherine
,
Mme TRUNTZER Caroline
,
Dr VEGRAN Frédérique
,
Dr BRUCHARD Mélanie
,
Dr CHALMIN Fanny
,
Dr BELLAYE Pierre-Simon
,
Dr THIBAUDIN Marion
Tous les auteurs :
Geindreau M, Pignol C, Coënon L, Varin A, Racoeur C, Milian L, Roger N, Chalmin F, Vernet T, Alibert L, Bellaye PS, Thibaudin M, Louis C, Wicks I, Truntzer C, Boidot R, Paul C, Lamarthée B, Vegran F, Ghiringhelli F, Bruchard M
Lien Pubmed
Résumé
The combination of antiangiogenic therapy with immune checkpoint blockade has demonstrated significant clinical benefits in various cancers, however, the precise mechanisms of action on the immune system are not fully understood. In particular, the early intratumoral immune responses induced by angiogenesis inhibition remain unclear.
Mots clés
Adaptive, Colorectal Cancer, Combination therapy, Immune Checkpoint Inhibitor, Natural killer - NK
Référence
J Immunother Cancer. 2026 06 22;14(6):
